Morrison Foerster was named a winner inThe National Law Journal'sTop 100 Verdicts of 2022. The firm was named for securing a complete victory for its client Seagen Inc. in patent litigation involving Seagen’s pioneering antibody-drug conjugate technology in a jury trial in Marshall, Texas, that concluded on April 8.
The jury in the U.S. District Court for the Eastern District of Texas found that Daiichi Sankyo willfully infringed Seagen’s patent (U.S. Patent No. 10,808,039) through sales of its Enhertu cancer treatment and held the patent not invalid. The jury awarded $41.8 million in damages—the entire amount Seagen requested.
The Morrison Foerster trial team representing Seagen included Michael Jacobs, Matthew Chivvis, Bryan Wilson, Matthew Kreeger, Sumaiya Sharmeen, Chris Han and Evelyn Chang.
To view a full list of winners, please visitThe National Law Journal'swebsite.